The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma

被引：0
|
作者：
Xin Xiao
Wei Wang
Zhen Wang
机构：
[1] Xijing Hospital,Department of Orthopedics
[2] Forth Military Medical University,The State Key Laboratory of Cancer Biology, Department of Immunology
[3] Forth Military Medical University,undefined
来源：
Pediatric Drugs | 2014年 / 16卷
关键词：
Gemcitabine; Osteosarcoma; Etoposide; Ifosfamide; Topotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 512
页数：9
相关论文
共 50 条
  • [1] The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma
    Xiao, Xin
    Wang, Wei
    Wang, Zhen
    PEDIATRIC DRUGS, 2014, 16 (06) : 503 - 512
  • [2] Molecular Changes in Progressive/Relapsed or Refractory Osteosarcoma
    Lutz, K.
    Barenboim, M.
    Baumhoer, D.
    Witt, O.
    Bielack, S.
    Burdach, S.
    Nathrath, M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S246 - S246
  • [3] High-dose chemotherapy with autologous stem cell transplantation for metastatic and relapsed osteosarcoma in children
    Park, J. A.
    Koh, K.
    Kang, H.
    Im, H.
    Park, K.
    Seo, J.
    Shin, H.
    Ahn, H.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S218 - S218
  • [4] The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma
    Bramwell, VHC
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 561 - 571
  • [5] Apatinib plus ifosfamide and etoposide (IE) versus IE chemotherapy alone for relapsed or refractory osteosarcoma.
    Xie, Lu
    Guo, Wei
    Xu, Jie
    Gu, Jin
    Tang, Xiaodong
    Li, Yuan
    Sun, Kunkun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] EXPERIENCE WITH PAZOPANIB IN RELAPSED, REFRACTORY OSTEOSARCOMA: A CASE REPORT
    Ishigaki, Ryusuke
    Meguro, Toru
    Sato, Hiroko
    Kawasaki, Naomi
    Uemura, Yuta
    Kanno, Miyako
    Mitsui, Tetsuo
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S35 - S35
  • [7] High dose chemotherapy in metastatic osteosarcoma
    Fagioli, F
    Del Prever, AB
    Tienghi, A
    Picci, P
    Bacci, G
    Biasin, E
    Vassallo, E
    Palmero, A
    Aglietta, M
    Madon, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S329 - S330
  • [8] Genome and transcriptome profiling of relapsed and metastatic osteosarcoma.
    Wu, Chia Chin
    Beird, Hannah
    Livingston, J. Andrew
    Cao, Shaolong
    Advani, Shailesh M.
    Ingram, Davis
    Wang, Wei-Lien
    Lazar, Alexander J.
    Reuben, Alexandre
    Zheng, Youyun
    Roszik, Jason
    Wang, Wenyi
    Gorlick, Richard Greg
    Benjamin, Robert S.
    Patel, Shreyaskumar
    Daw, Najat C.
    Futreal, Andrew
    Lewis, Valerae O.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Comparison of pirarubicin-based versus gemcitabine–docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience
    Aina He
    Weixiang Qi
    Yujing Huang
    Yuanjue Sun
    Zan Shen
    Hui Zhao
    Yumei Yang
    Yang Yao
    International Journal of Clinical Oncology, 2013, 18 : 498 - 505
  • [10] The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre-clinical study
    Low, Kaan
    Foulkes, Paola
    Hills, Frank
    Roberts, Helen C.
    Stordal, Britta
    CANCER MEDICINE, 2024, 13 (18):
12345